Category:Pages with missing NCBI ID
From BugSigDB
When resolving issues shown on this page, please read and make notes on the Discussion page to avoid duplicating work. See https://en.wikipedia.org/wiki/Open_nomenclature for help with nomenclature conventions, and use the NCBI Taxonomy Browser. Also here is a 2-hour video of Levi Waldron working on mapping issues on this page to the NCBI taxonomy.
Pages in category "Pages with missing NCBI ID"
The following 200 pages are in this category, out of 1,062 total.
(previous page) (next page)0–9
- Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans/Experiment 1/Signature 1
- Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1/Signature 2
- Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 2/Signature 2
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 1/Signature 2
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 3/Signature 1
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 5/Signature 1
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 5/Signature 2
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 6/Signature 1
- Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 6/Signature 2
- Effect of metformin on metabolic improvement and gut microbiota/Experiment 1/Signature 1
- Effect of metformin on metabolic improvement and gut microbiota/Experiment 5/Signature 2
- Gut microbiota are related to Parkinson's disease and clinical phenotype/Experiment 1/Signature 1
- Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes/Experiment 1/Signature 1
- Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 1/Signature 1
- Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 2/Signature 1
- Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 3/Signature 1
- Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes/Experiment 7/Signature 1
- Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome/Experiment 1/Signature 1
- Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome/Experiment 1/Signature 2
- Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome/Experiment 3/Signature 2
- Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma/Experiment 2/Signature 2
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 1/Signature 1
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 1/Signature 2
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 2/Signature 1
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 2/Signature 2
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 1/Signature 1
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 2/Signature 1
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 2/Signature 2
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 3/Signature 1
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 3/Signature 2
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 4/Signature 1
- Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status/Experiment 4/Signature 2
- Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 6/Signature 2
- Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 6/Signature 3
- Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 8/Signature 1
- Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients/Experiment 8/Signature 2
- Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls/Experiment 1/Signature 2
- Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses/Experiment 1/Signature 1
- Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses/Experiment 1/Signature 2
- Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses/Experiment 2/Signature 1
- Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses/Experiment 2/Signature 2
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 2/Signature 1
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 3/Signature 1
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 4/Signature 1
- Comparison of DNA extraction methods for human gut microbial community profiling/Experiment 2/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 1/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 2/Signature 2
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 3/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 5/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 6/Signature 2
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 12/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 14/Signature 2
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 1
- Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia/Experiment 17/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 2/Signature 1
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 2/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 3/Signature 1
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 3/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 4/Signature 1
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 4/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 5/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 6/Signature 1
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 8/Signature 1
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 9/Signature 2
- Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum/Experiment 10/Signature 2
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 1/Signature 2
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 2/Signature 1
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 3/Signature 1
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 2/Signature 2
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 3/Signature 2
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 4/Signature 1
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 5/Signature 1
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 6/Signature 1
- Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects/Experiment 7/Signature 1
- Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet/Experiment 2/Signature 1
- Microbial Similarity and Preference for Specific Sites in Healthy Oral Cavity and Esophagus/Experiment 1/Signature 1
- Microbial Similarity and Preference for Specific Sites in Healthy Oral Cavity and Esophagus/Experiment 1/Signature 2
- Microbial Similarity and Preference for Specific Sites in Healthy Oral Cavity and Esophagus/Experiment 4/Signature 1
- A metagenomic study of the gut microbiome in Behcet's disease/Experiment 2/Signature 1
- A metagenomic study of the gut microbiome in Behcet's disease/Experiment 3/Signature 1
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 1/Signature 1
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 2/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 3/Signature 1
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 3/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 4/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 1/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 2/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 3/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 4/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 10/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 16/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 17/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 19/Signature 1
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 20/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 21/Signature 1
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 23/Signature 1
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 24/Signature 1
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 27/Signature 2
- Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women/Experiment 28/Signature 1
- Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore/Experiment 3/Signature 1
- Zengye decoction induces alterations to metabolically active gut microbiota in aged constipated rats/Experiment 2/Signature 1
- Signatures within the esophageal microbiome are associated with host genetics, age, and disease/Experiment 16/Signature 1
- Signatures within the esophageal microbiome are associated with host genetics, age, and disease/Experiment 17/Signature 1
- The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls/Experiment 3/Signature 2
- Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 4/Signature 1
- Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 9/Signature 1
- Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut/Experiment 11/Signature 1
- Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 1
- Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders/Experiment 1/Signature 2
- Characterization of microbial communities in the chicken oviduct and the origin of chicken embryo gut microbiota/Experiment 1/Signature 2
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6/Signature 1
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6/Signature 2
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 9/Signature 1
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 11/Signature 1
- Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthma/Experiment 1/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 1/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 1/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 2/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 3/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 3/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 5/Signature 1
- The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 2/Signature 2
- The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 4/Signature 1
- The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 6/Signature 2
- The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 13/Signature 1
- The human microbiota is associated with cardiometabolic risk across the epidemiologic transition/Experiment 19/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 38/Signature 1
- Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment/Experiment 1/Signature 1
- Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 1
- Analysis of Salivary Microbiome in Patients with Alzheimer's Disease/Experiment 3/Signature 2
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 3/Signature 1
- Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course/Experiment 1/Signature 1
- Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course/Experiment 2/Signature 2
- Implications of gut microbiota dysbiosis and metabolic changes in prion disease/Experiment 1/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 1/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 3/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 5/Signature 1
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 6/Signature 1
- The composition of intestinal microbiota and its association with functional constipation of the elderly patients/Experiment 2/Signature 2
- Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 3/Signature 1
- Dysbiosis of saliva microbiome in patients with oral lichen planus/Experiment 1/Signature 1
- Dysbiosis of saliva microbiome in patients with oral lichen planus/Experiment 1/Signature 2
- The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection/Experiment 4/Signature 1
- The penile microbiota of Black South African men: relationship with human papillomavirus and HIV infection/Experiment 4/Signature 2
- Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression/Experiment 2/Signature 1
- Preconception helminth infection alters offspring microbiota and immune subsets in a mouse model/Experiment 4/Signature 1
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 1/Signature 2
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 2/Signature 1
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 1
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 3/Signature 2
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 1
- Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder/Experiment 4/Signature 2
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 1
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 2
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 2
- A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients/Experiment 2/Signature 2
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 3/Signature 2
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 4/Signature 2
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 5/Signature 2
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 6/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 8/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 10/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 11/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 13/Signature 1
- Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease/Experiment 15/Signature 1
- Changes in the vaginal microbiota associated with primary ovarian failure/Experiment 1/Signature 1
- Microbiota assembly, structure, and dynamics among Tsimane horticulturalists of the Bolivian Amazon/Experiment 1/Signature 1
- Microbiota assembly, structure, and dynamics among Tsimane horticulturalists of the Bolivian Amazon/Experiment 1/Signature 2
- Microbiota assembly, structure, and dynamics among Tsimane horticulturalists of the Bolivian Amazon/Experiment 2/Signature 1
- Microbiota assembly, structure, and dynamics among Tsimane horticulturalists of the Bolivian Amazon/Experiment 2/Signature 2
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 1/Signature 1
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 1/Signature 2
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 2/Signature 1
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 2/Signature 2
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 3/Signature 1
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 3/Signature 2
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 4/Signature 1
- Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation/Experiment 1/Signature 2
- Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation/Experiment 2/Signature 2
- Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition/Experiment 2/Signature 1
- Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition/Experiment 5/Signature 1
- Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition/Experiment 6/Signature 1
- Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition/Experiment 6/Signature 2
- The biological effects of microencapsulated organic acids and botanicals induces tissue-specific and dose-dependent changes to the Gallus gallus microbiota/Experiment 3/Signature 1
- The biological effects of microencapsulated organic acids and botanicals induces tissue-specific and dose-dependent changes to the Gallus gallus microbiota/Experiment 3/Signature 2
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 1/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 2/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 3/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 3/Signature 2
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 4/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 4/Signature 2
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 5/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 5/Signature 2
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 6/Signature 1
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 6/Signature 2
- Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys/Experiment 9/Signature 1
